- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01684501
Comparing Active and Passive Ankle-foot Prostheses
April 10, 2017 updated by: Paolo Bonato, Spaulding Rehabilitation Hospital
The purpose of this study is to perform a biomechanical study of a prototype prosthetic foot and evaluate if it provides a physiological generation of power at the ankle in transtibial amputees.
The prosthetic foot is a prototype system that generates power via actuators (i.e.
robotic system).
Study Overview
Status
Completed
Conditions
Detailed Description
Subjects will be studied during level-ground walking.
A camera-based motion capture system will be used to study the biomechanics of motion and evaluate if the pattern of ankle power generation by the prosthetic foot is physiological.
In addition, the metabolic cost of ambulation will be monitored during walking at constant speed over a period of several minutes.
The data will allow us to assess if the prosthetic foot leads to a decreased metabolic cost of ambulation compared to passive prosthetic feet.
Study Type
Observational
Enrollment (Actual)
6
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Spaulding Rehabilitation Hospital Boston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adults with history of traumatic unilateral transtibial amputation
Description
Inclusion Criteria:
- weigh more than 200 lbs
- are high level ambulators corresponding to levels E to F of the Special Interest Group of Amputee Medicine (SIGAM) mobility grade
- have the ability to follow multi-step commands.
Exclusion Criteria:
- score level D on the SIGAM mobility grade
- have experienced 1 or more falls in the last month before the study
- have a residual limb length which does not allow for seven inches clearance of bracket attachment for the PowerFoot
- the residual limb must be stable in volume (no change in socket or socket padding in last 6 months) and without pain that limits function
- the sound-side (contralateral) lower extremity must be free of impediments that affect gait, range of motion, or limb muscle activity
- Any diagnosed cardiovascular, pulmonary, neurological, and/ or orthopedic conditions that would interfere with subject participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Amputees
Adults with history of traumatic unilateral transtibial amputation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ankle power generation
Time Frame: During the session trial (approx 10 minutes)
|
Ankle power derived using a camera-based motion capture system during walking
|
During the session trial (approx 10 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic cost of ambulation
Time Frame: During the session trial (approx 10 minutes)
|
Oxygen consumption during level-ground walking
|
During the session trial (approx 10 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Paolo Bonato, Spaulding Rehabilitation Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2010
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
September 7, 2012
First Submitted That Met QC Criteria
September 12, 2012
First Posted (Estimate)
September 13, 2012
Study Record Updates
Last Update Posted (Actual)
April 12, 2017
Last Update Submitted That Met QC Criteria
April 10, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2010-P-000951
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trans-tibial Amputation
-
Sheba Medical CenterCompletedUnilateral Trans Tibial AmputationIsrael
-
University of British ColumbiaVancouver Coastal Health Research Institute; GF Strong Rehabilitation CentreCompletedUnilateral Trans Tibial/Femoral Lower Limb AmputationCanada
-
Brigham and Women's HospitalEnrolling by invitationLower Extremity Amputation | Trans-Tibial Amputation | Traumatic Lower Extremity Amputation | Agonist-Antagonist Myoneural InterfaceUnited States
-
Université de SherbrookeRecruitingTrans-tibial AmputationsCanada
-
University of PittsburghAmerican Orthotic and Prosthetic AssociationCompletedTrans-tibial Limb LossUnited States
-
University of HullHull University Teaching Hospitals NHS TrustUnknownUnilateral Trans-tibial AmputeesUnited Kingdom
-
University of DerbyUnknownPeople With Trans-femoral Amputation
-
Christian CandrianTerminatedTrans-femoral Amputated PatientsSwitzerland
-
Atlantia Food Clinical TrialsCompleted